Literature DB >> 935211

The role of locomotion in conditioning methylphenidate-induced locomotor activity.

H L Schreiber, G W Wood, R H Carlson.   

Abstract

This experiment determined whether overt performance of the entire response (actual running) was necessary for the conditioning of methylphenidate-induced locomotor activity (wheel-running) in guinea pigs. Four guinea pigs were given daily injections of 2.5 mg/kg methylphenidate and were allowed to run in activity wheels; 4 other guinea pigs were given methylphenidate and were placed in locked activity wheels; a third group of 4 guinea pigs were administered saline and allowed to locomote; a fourth group of 4 guinea pigs received saline injections and were placed in locked activity wheels. After 12 days of injection, all animals were given saline injections on the 9 subsequent days and allowed to run freely in the wheels. The 2 groups which had received methylphenidate showed more locomotor activity than the saline injected animals but were not distinguishable from each other on the basis of prior opportunity to engage in locomotor activity. These results were interpreted to indicate that (a) increased methylphenidate-induced locomotor activity may be conditioned with repeated administration of the drug, and (b) actual running is not essential for the conditioning of drug-induced wheel-running.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 935211     DOI: 10.1016/0091-3057(76)90053-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Scopolamine produces environment-specific conditioned activity that is not blocked by pimozide in rats.

Authors:  E J Mazurski; R J Beninger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  The effect of amygdala kindling on spontaneous and cocaine-induced motor activity and lidocaine seizures.

Authors:  R M Post; K M Squillace; A Pert; W Sass
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.